Robert N. Fried - Mar 16, 2022 Form 4 Insider Report for ChromaDex Corp. (CDXC)

Role
CEO, Director
Signature
/s/ Jeong James Lee, Attorney-in-Fact
Stock symbol
CDXC
Transactions as of
Mar 16, 2022
Transactions value $
$54,000
Form type
4
Date filed
3/16/2022, 07:28 PM
Previous filing
Feb 22, 2022
Next filing
Oct 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDXC Common Stock Purchase $54K +25K +39.68% $2.16 88K Mar 16, 2022 By Fried-Travis Revocable Trust U/A Dated 06/02/1999 F1
holding CDXC Common Stock 892K Mar 16, 2022 Direct F2
holding CDXC Common Stock 250K Mar 16, 2022 By US Trust Co. of Delaware Trustee of The Benjamin A Fried 2020 Irrevocable Trust dated 02/26/2020
holding CDXC Common Stock 250K Mar 16, 2022 By US Trust Co. of Delaware Trustee of The Jeremy W Fried 2020 Irrevocable Trust dated 02/26/2020
holding CDXC Common Stock 12.7K Mar 16, 2022 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction reported was $2.16, and the range of prices were between $2.14 and $2.16, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range above will be provided.
F2 On August 4, 2021, 9,753 shares previously owned indirectly by Fried Films Profit Sharing were transferred to Robert N Fried IRRA.
F3 6,745 shares held by Jeremy Fried and 6,001 shares held by Benjamin Fried, who are sons of Robert Fried.